HPV/Genital Warts Health Center

News and Features Related to HPV/Genital Warts

21. HPV Vaccine Gardasil for Boys?
    

    Sept. 8, 2009 -- An FDA advisory committee will meet Wednesday to consider whether to recommend approving the vaccine Gardasil for males ages 9 to 26. Gardasil targets four strains of human papillomavirus, commonly called HPV. The vaccine already has FDA approval for use in females ages 9 to 26. But

    Read Full Article
22. Is HPV Vaccine Benefit Exaggerated?
    

    Aug. 18, 2009 – Merck's Gardasil won the Pharmaceutical Executive 2006 "brand of the year" award for "creating a market out of thin air." But is the HPV vaccine oversold? The charge comes from a "special communication" and an editorial in the Aug. 19 issue of The Journal of the American Medical Asso

    Read Full Article
23. HPV Linked to Throat Cancer Survival
    

    July 29, 2009 -- As a group, blacks with head and neck cancer have a much lower survival rate than whites with the disease, and now groundbreaking new research helps explain why. The study sheds new light on the racial differences in head and neck cancer presentation and outcomes, and experts say th

    Read Full Article
24. Oral Sex Cause of Throat Cancer Rise
    

    July 29, 2009 - Changing sexual practices have led to a dramatic rise in throat cancer in the United States over the past two decades, and experts say they fear an epidemic of the disease. The comments were made Wednesday at a news conference held by the American Association for Cancer Research to d

    Read Full Article
25. HPV Vaccine Gardasil May Help Boys, Men
    

    Nov. 13, 2008 -- Gardasil, a vaccine against four strains of human papillomavirus (HPV), may help prevent genital warts in boys and men. That's according to a new study presented this week in Nice, France, at the annual meeting of the European Research Organization on Genital Infection and Neoplasia

    Read Full Article
26. At Least 25,000 HPV-Linked Cancers a Year
    

    Nov. 3, 2008 -- About 25,000 cases of cancers associated with the human papillomavirus (HPV) occurred annually in 38 states and Washington, D.C., between 1998 and 2003, says a new report by the CDC. "These estimates of HPV-associated cancers were collected prior to the development of the HPV vaccine

    Read Full Article
27. Gardasil Passes a 2-Year Safety Check
    

    Oct. 22, 2008 -- Two years after Gardasil's approval, safety monitors detect no major safety problems with the HPV vaccine. Gardasil protects against infection with dangerous strains of HPV, the sexually transmitted virus that causes cervical cancer and genital warts. The CDC recommends that girls g

    Read Full Article
28. Experts: HPV Vaccine a Preteen Priority
    

    Aug. 20, 2008 -- The vaccine against human papillomavirus (HPV), the sexually transmitted virus that causes cervical cancer, will be most cost-effective in the U.S. with universal vaccination of 12-year-old girls and catch-up efforts to vaccinate girls and women ages 13 to 21, say Harvard researcher

    Read Full Article
29. Early Sex Doesn't Predict HPV Infection
    

    July 7, 2008 -- Teenage girls who are sexually active and those who are not eventually all have the same risk for infection with the human papilloma virus (HPV), new research suggests. The finding that early sexual activity is not predictive of future HPV infection suggests that using risk factors a

    Read Full Article
30. What Parents Should Know About the HPV, or Cervical Cancer, Vaccine
    

    You've probably heard that a new HPV vaccine can protect women against cervical cancer. In fact, the vaccine may be most effective when given to girls and young women. Is the HPV vaccine something you should consider for your daughter? Is this vaccine safe? When should girls receive the shots, and a

    Read Full Article